Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Alexandre Fredenrich"'
Autor:
Rami Batal, Michel Tremblay, P. Hugh R. Barrett, Hélène Jacques, Alexandre Fredenrich, Orval Mamer, Jean Davignon, Jeffrey S. Cohn
Publikováno v:
Journal of Lipid Research, Vol 41, Iss 5, Pp 706-718 (2000)
Apolipoprotein (apo) C-III and apoE play a central role in controlling the plasma metabolism of triglyceride-rich lipoproteins (TRL). We have investigated the plasma kinetics of total, very low density lipoprotein (VLDL) and high density lipoprotein
Externí odkaz:
https://doaj.org/article/1641b8314fc8483aa3721bc22c1ed2e7
Autor:
Olivier Ziegler, Philippe Moulin, J.D. Lalau, Franck Boccara, Michel Farnier, B. Vergès, Michel Krempf, Sophie Béliard, Mondher Toumi, Noël Peretti, Régis Hankard, Valérie Carreau, V. Durlach, Alain Carrié, David Rosenbaum, Gérald Luc, F. Paillard, P. Moulin, Patrick Tounian, Aurélie Millier, Denis Angoulvant, Jean Ferrières, G. Luc, E. Bruckert, Eric Bruckert, A. Pradignac, S. Béliard, Y. Pucheu, Alexandre Fredenrich
Publikováno v:
Journal of clinical lipidology
Journal of clinical lipidology, Elsevier, 2016, 10 (5), pp.1129-1136. ⟨10.1016/j.jacl.2016.06.007⟩
Journal of clinical lipidology, Elsevier, 2016, ⟨10.1016/j.jacl.2016.06.007⟩
Journal of clinical lipidology, Elsevier, 2016, 10 (5), pp.1129-1136. ⟨10.1016/j.jacl.2016.06.007⟩
Journal of clinical lipidology, Elsevier, 2016, ⟨10.1016/j.jacl.2016.06.007⟩
International audience; BACKGROUND: Heterozygous familial hypercholesterolemia (heFH) is a genetic disease causing high levels of low-density lipoprotein cholesterol (LDL-C). Although this population is at high cardiovascular (CV) risk, the risk is v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0780ef2eaa3ea1c4fa0c47c1bb933d
https://hal.archives-ouvertes.fr/hal-01479071
https://hal.archives-ouvertes.fr/hal-01479071
Autor:
Joaquin Lopez-Soriano, Paul Grimaldi, Serge Luquet, Dorte Holst, Alexandre Fredenrich, Céline Gaudel, Chantal Jehl-Pietri
Publikováno v:
Biochimie. 86:833-837
Peroxisome proliferator-activated receptors (PPARs) are lipid-activated transcription factors playing important regulatory functions in development and metabolism. PPARalpha and PPARgamma are the most extensively examined and characterized, mainly be
Autor:
Paul Grimaldi, Alexandre Fredenrich
Publikováno v:
Current Opinion in Clinical Nutrition and Metabolic Care. 7:377-381
PURPOSE OF THE REVIEW Peroxisome proliferator-activated receptors mediate the transcriptional effects of fatty acids and fatty acid metabolites and regulate many physiological functions including development and metabolism. The roles of peroxisome pr
Autor:
Yves Reznik, Dorothée Briffaut, Alexandre Fredenrich, Sabine Amsellem, Jean-Pierre Rabès, J.P. Girardet, Pascale Benlian, Jean Luc De Gennes, Michel Krempf, Eric Brukert, Alain Carrié, Bernard Vialettes, Philippe Moulin
Publikováno v:
Human Genetics. 111:501-510
Familial hypercholesterolemia (FH), a frequent monogenic condition complicated by premature cardiovascular disease, is characterized by high allelic heterogeneity at the low-density lipoprotein receptor (LDLR) locus. Despite more than a decade of gen
Autor:
G. Luc, Alain Carrié, Valérie Carreau, Jean Ferrières, Eric Bruckert, P. Moulin, Michel Krempf, Philippe Giral, Alexandre Fredenrich, Michel Farnier, E. Duchêne, S. Béliard
Publikováno v:
Atherosclerosis
Atherosclerosis, Elsevier, 2014, 234 (1), pp.136-41. ⟨10.1016/j.atherosclerosis.2014.02.021⟩
Atherosclerosis, Elsevier, 2014, 234 (1), pp.136-41. ⟨10.1016/j.atherosclerosis.2014.02.021⟩
International audience; BACKGROUND: Heterozygous Familial Hypercholesterolemia (heFH) is an autosomal disease that affects about 1/500 people. It is characterized by markedly elevated plasma LDL-cholesterol (C) levels and an increased risk of cardiov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de577abcb728f8cc8a566e30ab49cfb7
https://hal.archives-ouvertes.fr/hal-01859380
https://hal.archives-ouvertes.fr/hal-01859380
Publikováno v:
Metabolism. 50:112-119
The distribution of apolipoprotein C-III (apoC-III) between high-density lipoprotein (HDL) and apoB-containing lipoproteins has been used in lipid-lowering angiographic trials to establish a link between impaired triglyceride (TG)-rich lipoprotein (T
Autor:
Alexandre Fredenrich, Pascale Bayer
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 185:41-47
RESUME A l’inverse des lipoproteines de basse densite (LDL), dont l’elevation est directement liee au risque de maladie coronarienne, les lipoproteines de haute densite (HDL) ont un role antiatherogene, en assurant le retour du cholesterol des ti
Autor:
Michel Tremblay, Hélène Jacques, Jeffrey S. Cohn, Alexandre Fredenrich, P. Hugh R. Barrett, Orval A. Mamer, Rami Batal, Jean Davignon
Publikováno v:
Scopus-Elsevier
Journal of Lipid Research, Vol 41, Iss 5, Pp 706-718 (2000)
Journal of Lipid Research, Vol 41, Iss 5, Pp 706-718 (2000)
Apolipoprotein (apo) C-III and apoE play a central role in controlling the plasma metabolism of triglyceride-rich lipoproteins (TRL). We have investigated the plasma kinetics of total, very low density lipoprotein (VLDL) and high density lipoprotein
Autor:
Alexandre Fredenrich, Philippe Lapalus, S. Hieronimus, Michel Harter, Pascale Bayer, D. Jambou
Publikováno v:
Atherosclerosis. 142:217-224
We have previously shown that low-density (LDL) and high-density (HDL) lipoprotein from healthy subjects can promote in vitro prostaglandin (PG) release by murine macrophages. In this pilot study, we have measured PG production induced by lipoprotein